July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Browse healthtech venture capital articles below.
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.
Junction, now headquartered in New York, announced an $18M funding round on March 11, 2025, to scale infrastructure linking wearable data and lab workflows.